History | Empagliflozin for treating chronic kidney disease | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 143 KB)

Published:

20 December 2023

Final draft guidance

Final draft guidance
Committee papers (PDF 10.48 MB)

Published:

17 November 2023
Final appraisal document Equality Impact Assessment (PDF 143 KB)

Published:

17 November 2023
Final draft guidance (PDF 142 KB)

Published:

17 November 2023

Invitation to participate

Invitation to participate
Final scope (PDF 202 KB)

Published:

25 April 2023
Final stakeholder list (PDF 159 KB)

Published:

25 April 2023
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 618 KB)

Published:

25 April 2023
Equality impact assessment (Scoping) (PDF 127 KB)

Published:

25 April 2023

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft matrix post referral (PDF 160 KB)

Published:

02 November 2022
Draft scope post referral (PDF 211 KB)

Published:

02 November 2022